
Understanding the Mode of Action of REZUROCK▼(belumosudil)
This website contains promotional content and is intended for Healthcare Professionals based in the United Kingdom only. Some content may only be relevant to HCPs practising in Great Britain (England, Scotland and Wales) according to product availability. This website is optimised for desktop use, and some features may perform differently on mobile devices.
Adverse event reporting can be found at the bottom of the page.


%20(1).jpg)

A practical guide for initiating or switching patients to a new insulin

Beyfortus®▼ (nirsevimab)

Efficacy and safety considerations are essential for effective Type 2 diabetes management.

A short video raising awareness of Pompe disease

.jpg)

Read to learn more about what tools can help you identify your patients with uncontrolled AD
MAT-XU-2305061 (v2.0) Date of preparation: February 2024